Singapore markets closed

Elanco Animal Health Incorporated (ELAN)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
16.28+0.11 (+0.68%)
At close: 04:00PM EDT
16.41 +0.13 (+0.80%)
After hours: 05:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.97B
Enterprise value 13.39B
Trailing P/E N/A
Forward P/E 17.01
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.80
Price/book (mrq)1.28
Enterprise value/revenue 3.03
Enterprise value/EBITDA -59.79

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 377.89%
S&P500 52-week change 329.57%
52-week high 316.88
52-week low 37.88
50-day moving average 315.72
200-day moving average 312.61

Share statistics

Avg vol (3-month) 34.43M
Avg vol (10-day) 32.96M
Shares outstanding 5492.97M
Implied shares outstanding 6492.97M
Float 8490.57M
% held by insiders 10.65%
% held by institutions 199.20%
Shares short (15 Mar 2024) 412.98M
Short ratio (15 Mar 2024) 42.92
Short % of float (15 Mar 2024) 43.20%
Short % of shares outstanding (15 Mar 2024) 42.63%
Shares short (prior month 15 Feb 2024) 411.97M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -27.87%
Operating margin (ttm)1.64%

Management effectiveness

Return on assets (ttm)1.39%
Return on equity (ttm)-18.22%

Income statement

Revenue (ttm)4.42B
Revenue per share (ttm)8.97
Quarterly revenue growth (yoy)5.10%
Gross profit (ttm)N/A
EBITDA 973M
Net income avi to common (ttm)-1.23B
Diluted EPS (ttm)-2.50
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)352M
Total cash per share (mrq)0.71
Total debt (mrq)5.92B
Total debt/equity (mrq)95.07%
Current ratio (mrq)2.74
Book value per share (mrq)12.63

Cash flow statement

Operating cash flow (ttm)271M
Levered free cash flow (ttm)388M